When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Glioblastoma - Wikipedia

   en.wikipedia.org/wiki/Glioblastoma

   Glioblastoma, previously known as glioblastoma multiforme (GBM), is the most aggressive and most common type of cancer that originates in the brain, and has a very poor prognosis for survival. [ 6 ] [ 7 ] [ 8 ] Initial signs and symptoms of glioblastoma are nonspecific. [ 1 ]

3. Gliosarcoma - Wikipedia

   en.wikipedia.org/wiki/Gliosarcoma

   Between 40 and 60 years old [2] Prognosis: Five-year survival rate: 5.6% [2] ... is classified as a grade IV tumor and a subtype of glioblastoma multiforme in the ...

4. Malcolm Stevens - Wikipedia

   en.wikipedia.org/wiki/Malcolm_Stevens

   [2] [6] Stevens's lab synthesised Temozolomide, which as of 2019, remains the only FDA-approved drug to treat the deadly brain tumor Glioblastoma multiforme. Temozolomide has had a substantial impact in the clinic: the 5-year survival with radiation alone is 4%, whilst with radiation plus temozolomide, it approaches 17%.

5. Glioma - Wikipedia

   en.wikipedia.org/wiki/Glioma

   This group comprises anaplastic astrocytomas and glioblastoma multiforme. Whereas the median overall survival of anaplastic (WHO grade III) gliomas is approximately 3 years, glioblastoma multiforme has a poor median overall survival of c. 15 months. [86]

6. Neuro-oncology - Wikipedia

   en.wikipedia.org/wiki/Neuro-oncology

   Neuro-oncology is the study of brain and spinal cord neoplasms, many of which are (at least eventually) very dangerous and life-threatening (astrocytoma, glioma, glioblastoma multiforme, ependymoma, pontine glioma, and brain stem tumors are among the many examples of these).

7. Adjuvant therapy - Wikipedia

   en.wikipedia.org/wiki/Adjuvant_therapy

   In glioblastoma multiforme, ... 5-year survival rate is 85% if adjuvant chemotherapy and/or craniospinal irradiation is performed, and just 10% if no adjuvant ...